These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 80871)
1. Biologic tumor markers in management of testicular and bladder cancer. Javadpour N Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871 [TBL] [Abstract][Full Text] [Related]
2. The role of biologic tumor markers in testicular cancer. Javadpour N Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517 [No Abstract] [Full Text] [Related]
3. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors. Thompson DK; Haddow JE Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255 [No Abstract] [Full Text] [Related]
4. Applications of biologic tumor markers in testicular cancer. Javadpour N Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433 [TBL] [Abstract][Full Text] [Related]
5. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors. Lange PH Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163 [TBL] [Abstract][Full Text] [Related]
6. Serum and cellular biologic tumor markers in patients with urologic cancer. Javadpour N Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569 [TBL] [Abstract][Full Text] [Related]
8. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study. Javadpour N; Soares T Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418 [TBL] [Abstract][Full Text] [Related]
9. [Tumor marker in urology]. Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269 [TBL] [Abstract][Full Text] [Related]
10. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma. Javadpour N; McIntire KR; Waldmann TA; Bergman SM J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391 [No Abstract] [Full Text] [Related]
11. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Lippert MC; Javadpour N Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417 [TBL] [Abstract][Full Text] [Related]
12. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281 [No Abstract] [Full Text] [Related]
13. Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers. Javadpour N; Utz M; Soares T J Urol; 1980 Nov; 124(5):615-6. PubMed ID: 6161257 [TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in germ cell tumors. Clinical use and research aspects]. Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594 [No Abstract] [Full Text] [Related]
16. [Determination of specific markers in the blood in tumors of the testis]. Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352 [No Abstract] [Full Text] [Related]
18. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors. Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A Oncology; 1983; 40(1):1-10. PubMed ID: 6185897 [TBL] [Abstract][Full Text] [Related]
19. Current concepts in management of testicular tumor. Javadpour N Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873 [No Abstract] [Full Text] [Related]
20. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours. Narayana AS; Loening S; Culp DA Br J Urol; 1978 Dec; 50(7):605-8. PubMed ID: 88986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]